Plethora grows urogynae pipeline with Metris agreement
This article was originally published in Clinica
Executive Summary
London-based specialty pharmaceutical company Plethora Solutions has licensed from fellow UK company Metris Therapeutics two clinical-stage compounds and a drug delivery technology designed to provide safer and more efficacious treatment of two common urogynaecology conditions, dysmenorrhea and endometriosis.